Associations of High‐Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT

Associations of High‐Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT

Background Assessing the risk of serious adverse events (SAEs) during hypertension treatment is important for understanding the benefit‐harm trade‐offs of lower blood pressure goals. It is unknown whether high‐sensitivity cardiac troponin T (hs‐cTnT) and N‐terminal pro‐B‐type natriuretic peptide (NT...

Full description

Bibliographic Details
Main Authors: Simon B. Ascher, Rebecca Scherzer, Jame A. de Lemos, Michelle M. Estrella, Vasantha K. Jotwani, Pranav S. Garimella, Alexander L. Bullen, Walter T. Ambrosius, Christie M. Ballantyne, Vijay Nambi, Anthony A. Killeen, Joachim H. Ix, Michael G. Shlipak, Jarett D. Berry
Format: Article
Language:English
Published: Wiley 2022-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
adverse events
brain natriuretic peptide
hypertension
SPRINT
troponin
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.023314

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.023314

Similar Items